InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
+2.4%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Salmon Sean, Vice-Président Exécutif et Président, Diabète/Cardiovasculaire. Director active across 1 company, notably Medtronic plc. Cumulatively, 19 filings have been recorded. Activity tracked since 2 August 2021. The latest transaction was disclosed on 16 December 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations19 total
645 shares@ US$82.482.2% of flowOrdinary SharesSEC:0001613103-24-000178:0
5,462 shares0Ordinary SharesSEC:0001613103-24-000116:0
14,375 shares0Ordinary SharesSEC:0001613103-24-000092:0
1,594 shares@ US$62.764.1% of flowOrdinary SharesSEC:0001613103-24-000008:0
435 shares@ US$79.271.4% of flowOrdinary SharesSEC:0001613103-23-000162:0
5,604 shares0Ordinary SharesSEC:0001613103-23-000097:0
9,686 shares0Ordinary SharesSEC:0001613103-23-000076:0
1,808 shares@ US$55.324.2% of flowOrdinary SharesSEC:0001127602-22-027593:0
300 shares@ US$79.041.0% of flowOrdinary SharesSEC:0001127602-22-027194:0
8,595 shares0Ordinary SharesSEC:0001127602-22-020417:0
5,808 shares0Ordinary SharesSEC:0001127602-22-020216:0
89 shares@ US$104.940.0000% mcap0.4% of flowOrdinary SharesSEC:0001127602-21-031183:0
89 shares@ US$104.940.4% of flowOrdinary SharesSEC:0001127602-21-031183
245 shares@ US$122.980.0000% mcap1.3% of flowOrdinary SharesSEC:0001127602-21-028742:0
245 shares@ US$122.981.2% of flowOrdinary SharesSEC:0001127602-21-028742
21,129 shares@ US$38.810.0007% mcap35.5% of flowOrdinary SharesSEC:0001127602-21-024367:0
21,129 shares@ US$38.8130.9% of flowOrdinary SharesSEC:0001127602-21-024367
2,272 shares@ US$131.310.0003% mcap12.8% of flowOrdinary SharesSEC:0001127602-21-023105:0
2,272 shares@ US$131.3111.1% of flowOrdinary SharesSEC:0001127602-21-023105
19 of 19 declarations
About Salmon Sean
Sean Salmon is the Executive Vice President and President of the Diabetes/Cardiovascular division at Medtronic plc. He oversees operations and product development in this critical health sector. With a strong background in management and innovation, he strives to improve patient outcomes and expand access to healthcare. His leadership is essential to Medtronic's mission.
